QA: Turning Point Therapeutics Inc in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001595893_2022_Turning_Point_Therapeutics_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001595893, Turning Point Therapeutics Inc

  xvar xval
0 AssetsCurrent 992,462,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 3,822,000
3 remainder_Assets 7,179,000
4 LiabilitiesCurrent 47,089,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 75,850,000
9 ResearchAndDevelopmentExpense 192,979,000
10 remainder_Expenses 0
11 remainder_Revenues 32,278,000
12 remainder_NetIncome 0
13 remainder_ComprehensiveNetIncome -1,483,000
  yvar yval
0 Assets 1,003,463,000
1 Liabilities 47,089,000
2 Expenses 268,829,000
3 Revenues 32,278,000
4 StockholdersEquity 956,374,000
5 NetIncome -236,551,000
6 ComprehensiveNetIncome -237,292,500
7 BaseVar 676,571,000
8 EconomicCapitalRatiobeforeLimitedLiability 3.52
9 EconomicCapitalRatio 4.04

Edgar->Model Mapping

Feature Distribution

Change over Time